Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study-Reference-Cited by-同舟云学术

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Published:2017-11-14 Issue: Volume:8 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Nyström Thomas,Santos-Pardo Irene,Hedberg Fredric,Wardell Johan,Witt Nils,Cao Yang,Bojö Leif,Nilsson Bo,Jendle Johan

Funder

Hjärt-Lungfonden

Svenska Läkaresällskapet

Stockholms Läns Landsting

Novo Nordisk

Svenska Sällskapet för Medicinsk Forskning

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference36 articles.

1. The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance;Nystrom;Horm Metab Res,2008

2. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

3. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study;From;J Am Coll Cardiol,2010

4. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion;Nikolaidis;Circulation,2004

5. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure;Sokos;J Card Fail,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of glucagon‐like peptide‐1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2024-03-26

2. Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial;Diabetes & Metabolism Journal;2023-09-30

3. Effects of Liraglutide on Diastolic Function Parameters in Patients with Type 2 Diabetes and Coronary Heart Disease;Advances in Clinical Medicine;2023

4. Glimepiride use is associated with reduced cardiovascular mortality in patients with type 2 diabetes and chronic heart failure: a prospective cohort study;European Journal of Preventive Cardiology;2022-12-27

5. Comparison of the effects of exenatide and insulin glargine on right and left ventricular myocardial deformation as shown by 2D-speckle-tracking echocardiograms;Nigerian Journal of Clinical Practice;2022